0000899243-15-002781.txt : 20150811
0000899243-15-002781.hdr.sgml : 20150811
20150811114014
ACCESSION NUMBER: 0000899243-15-002781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150811
FILED AS OF DATE: 20150811
DATE AS OF CHANGE: 20150811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001631650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452748244
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
BUSINESS PHONE: (650) 614-5220
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
FORMER COMPANY:
FORMER CONFORMED NAME: Allergen Research Corp
DATE OF NAME CHANGE: 20150123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iwicki Mark T
CENTRAL INDEX KEY: 0001415537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 151043026
MAIL ADDRESS:
STREET 1: 84 WATERFORD DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-11
0
0001631650
Aimmune Therapeutics, Inc.
AIMT
0001415537
Iwicki Mark T
C/O AIMMUNE THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 300
BRISBANE
CA
94005-1884
1
0
0
0
Common Stock, $0.0001 par value
2015-08-11
4
P
0
20000
16.00
A
20000
D
Reporting Person purchased 20,000 shares of Issuer's common stock in connection with the initial public offering at the offering price of $16.00 per share.
/s/ Warren L. DeSouza, as Attorney-in-Fact for Mark T. Iwicki
2015-08-11